Global Mupirocin Ointment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Mupirocin Ointment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Mupirocin Ointment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mupirocin Ointment market is projected to reach US$ 369.6 million in 2034, increasing from US$ 316.8 million in 2022, with the CAGR of 2.2% during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
Currently, global production of Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is Glenmark Pharms, who owns 37% revenue market share.
As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share.
Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest one.
Above 20g Mupirocin Ointment accounted for a major share of 30% the global Mupirocin Ointment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mupirocin Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sales Channel and Regions Listed in the Report
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
Segment by Type
Below 10g
10g-20g
Above 20g
Segment by Sales Channel
Hospital
Retail Pharmacy
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mupirocin Ointment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mupirocin Ointment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mupirocin Ointment industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Mupirocin Ointment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sales Channel, Volume and Revenue analysis of Each Sales Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mupirocin Ointment introduction, etc. Mupirocin Ointment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Mupirocin Ointment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Mupirocin Ointment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mupirocin Ointment market is projected to reach US$ 369.6 million in 2034, increasing from US$ 316.8 million in 2022, with the CAGR of 2.2% during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
Currently, global production of Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is Glenmark Pharms, who owns 37% revenue market share.
As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share.
Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest one.
Above 20g Mupirocin Ointment accounted for a major share of 30% the global Mupirocin Ointment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mupirocin Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sales Channel and Regions Listed in the Report
By Company
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
Segment by Type
Below 10g
10g-20g
Above 20g
Segment by Sales Channel
Hospital
Retail Pharmacy
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mupirocin Ointment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mupirocin Ointment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mupirocin Ointment industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Mupirocin Ointment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sales Channel, Volume and Revenue analysis of Each Sales Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mupirocin Ointment introduction, etc. Mupirocin Ointment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Mupirocin Ointment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.